Introduction: The objective of this study was to describe a pharmacokinetic-pharmacodynamic (PK/PD) approach for determination of a rational dosage of ampicillin (AMP) and depletion of the antibiotic residues in milk after intramammary administration to cows. Material and Methods: The cows came from different farms from the Lublin Province area. They (n = 9) received 5 g of the drug, containing 75 mg of AMP sodium in physiological solution, through a syringe tube by intramammary administration. Following single intramammary administration, the milk samples (5 mL) were collected after 2, 4, 6, 8, 10, 24, 36, 48, and 60 h. The liquid chromatography-mass spectrometry analysis was performed on the Agilent 1200 system connected to an AB Sciex API 4000™ mass spectrometer. The pharmacokinetic analysis of the concentrations of the antibiotic in milk was performed using software Phoenix ® WinNonlin ® 6.4. Calculations were made in non-compartmental (slopes, highest, amounts, and moments) and compartmental analysis. Results: The pharmacokinetic characteristics of AMP after intramammary administration indicate rapid elimination of the drug from milk. The mean residence time had a several-fold lower value than the designated elimination half-life and amounts to only 3.4 h. The concentration of the drug in the milk dropped relatively quickly and the process was very dynamic. Conclusion: The conducted research confirms the rationale of using the PK/PD model in order to verify the dosing regimen for other antibiotic groups and various indicators of the applied PK/PD model.
Introduction
Inflammation of the mammary gland in cows is an important sanitary-epidemiological and economical issue (18) . A principle in the treatment of mastitis is the introduction of therapeutic agents into the mammary gland quarters devoid of inflammatory secretions, if not accompanied by inflammation of the overall reaction system. Antibiotics should only be used when justified, due to the fact that any abuse may cause unintended reactions, regardless of the general contraindications concerning introduction thereof to the environment (2, 5) . A number of veterinary products containing β-lactam antibiotics are used to control mastitis in cows. Among them are aminopenicillins, which include, for example, ampicillin (2, 5, 17, 21) .
Ampicillin is commonly used in veterinary medicine due to its broader spectrum when confronted with natural penicillins, low treatment cost, and safety. Compared to penicillins G, ampicillin has a better ability to penetrate the external layer of cell membrane and, subsequently, has a much broader spectrum of activity against many Gram-negative bacteria (e.g. Enterobacteriaceae family) (20) . A significant limitation in its therapeutic usage is the increasing antibiotic resistance to aminopenicillins. Therefore, in order to reduce the number of unsuccessful therapies resulting from antibiotic resistance, a combination of pharmacokinetics/pharmacodynamics parameters (PK/PD), i.e. a PK/PD model, has been introduced in human and veterinary medicine (14, 26) . The PK/PD parameters used in this model include AUC/MIC, time of retention of the antibiotic above the minimal inhibitory concentration (MIC) value %T>MIC, and Cmax/MIC. In the case of antibiotics whose effect depends on how much time the concentration remains above the MIC level (β-lactams, macrolides), the role of %T>MIC is decisive for predicting their efficacy. For these antibiotics, the %T>MIC values should reach 50% -80% after the first and next doses (30) .
Inappropriate use of ampicillin in animal treatment may result in the presence of antibiotic residues in food of animal origin. Antibiotic residues in milk produced by cows treated pose a risk to human health (5, 14, 18) . Given the potential threat to human health, the European Commission established maximal residue limits (MRL) for ampicillin in milk (4 µg/kg) (11) . Therefore, particular attention was paid to the introduction of selective analytical methods for monitoring antibiotic residues in milk. Additionally, pharmacokinetic studies with ampicillin agents for determination of the withdrawal periods were conducted. The pharmacokinetic profile of ampicillin has been presented in several publications (6-9, 12, 13, 23, 25) . Ampicillin has been studied on alpacas, llamas (4, 23, 24) , lactating sheep and goats (9) , cattle (16), female buffaloes (22) , and neonatal calves (13) . However, up to now, there has been no research on ampicillin pharmacokinetics in cow's udder after single intramammary administration. The additional objective of this study was to describe a PK/PD approach for determination of a rational dosage of ampicillin and depletion of the antibiotic residues in milk.
Material and Methods
The study was conducted on Polish Black-White dairy cows (n = 9) at the age of 4-10 years with inflammation of the mammary gland. The cows, coming from different farms from the Lublin Province area, were qualified for the research on guidance from the owners. The animals were verified using the Draminski Mastitis Detector 4×4Q (Dramiński®, Poland), a four-quarter device for detecting subclinical mastitis in its earliest, visually undetectable stage, in order to assess the somatic cell count. The cows with a somatic cell count ≥400 000/mL were classified for the study. They received intramammary 5 g of the drug, containing 75 mg of ampicillin sodium in physiological solution, in a syringe tube. Internal standard (IS) of sulfafenazole was from Sigma-Aldrich (USA). The antibiotic was used lege artis. Before the collection of milk samples, the teats were cleaned and immersed in a liquid disinfectant-Avitaderm (Agrovet, Poland). Afterwards, teat mouths were wiped with a swab soaked in 70% ethanol. Milk samples (5 mL) were collected after 2, 4, 6, 8, 10, 24, 36, 48 , and 60 h after antibiotic administration. The milk samples were transferred into dark plastic bottles and kept in a cooler with ice until transported to laboratory.
In order to examine the efficacy of the ampicillin under in vitro conditions in mastitis cases, the PK/PD model was used. The model was implemented based on the pharmacokinetic analysis of ampicillin concentration in cows' milk. Additionally, %T>MIC was used as a pharmacokinetic indicator. The %T>MIC is the best prognostic indicator of the potential efficacy of antibiotics (e.g. β-lactamase), whose antibacterial effect depends on the time of action in an infected site.
Liquid chromatography-mass spectrometry (LC-MS/MS). LC-MS/MS analysis was performed using the Agilent 1200 LC system (Agilent Technologies, Germany) connected to an AB Sciex API 4000™ mass spectrometer (AB Sciex, Canada). The chromatographic separation was performed on the Luna ® octadecyl (C18) column (150 × 2.0 mm, 3 µm) (Phenomenex) coupled with an octadecyl guard column (2 × 4 mm) (Phenomenex), which was maintained at 30°C. The flow rate of the mobile phase was 250 µL per min, whilst the injection volume was 30 µL. The optimal composition of mobile phases A and B consisted of acetonitrile (A) and 0.025% heptafluorobutyric acid (HFBA) (B). The mobile phase gradient programme started at 95% of B, decreased to 60% of B for 2 min, and then to 10% of B for 9 min held for 2 min. After 11 min it was returned to the initial composition and equilibrated for another 14 min before the next injection.
Ampicillin analytical method. Ampicillin was extracted from 2 g of milk sample with 8 mL of acetonitrile. The IS was added before sample extraction, left to incubate at 4°C in the dark for 30 min, mixed with a vortex mixer for 1 min, mechanically shaken for 10 min, and then centrifuged at 1856 × g for 10 min at 5°C. Six millilitres of the supernatant were transferred to glass tubes and placed in a nitrogen evaporator at 45°C to dryness. The dry residues were dissolved in 600 µL of 0.025% HFBA and filtered through 0.45 mm PVDF syringe filters into chromatographic vials (500 µL).
Pharmacokinetics and statistical analysis. The pharmacokinetic analysis of milk concentrations of the antibiotic was performed using the software Phoenix ® WinNonlin ® 6.4 (Certara L.P., USA). Calculations were carried out regardless of the compartmental model in the range of slopes, highest, amounts, and moments (SHAM) analysis. In the SHAM analysis, the following were calculated: AUC0-t -area under the curve calculated between zero and the last sampling point; AUC0-inf -area under the curve calculated between zero and infinity; AUMC0-t -area under the first moment of curve calculated between zero and the last sampling point; AUMC0-inf -area under the first moment of curve calculated between zero and infinity; MRT0-tmean residence time calculated for the last sampling point; MRT0-inf -mean residence time calculated for infinity; AUCrest% -percentage of the rest area under the curve; Cmax -maximal concentration; tmax -time to rich maximal concentration; Clast -the last measured concentration; tlast -time of the last measured concentration (15, 16, 22, 27) .
A two-compartment model of the distribution of ampicillin in the cow's udder was also proposed. The teat canal and a teat cistern (milk compartment) were determined as the first compartment. The second compartment was the udder tissue compartment (tissue compartment). Within the compartment kinetics, the following were calculated: kel -elimination rate constant (from the last three concentrations); kddistribution rate constant; t1/2kel -elimination half-life; t1/2kd -distribution half-life; B -concentration extrapolated by elimination phase; A -concentration extrapolated by distribution phase; C0 -zero concentration; k10 -elimination rate from milk compartment; k20 -elimination rate from tissue compartment; k12 -rate constant between milk and tissue concentration; k21 -rate constant between tissue and milk concentration; CL -total clearance; V1 -milk compartment volume; V2 -tissue compartment (17, 19, 22, 28) .
Assessment of ampicillin efficacy under in vitro conditions with the PK/PD model. The assessment of ampicillin efficacy under in vitro conditions was performed with the %T>MIC rate in relation to MIC values acquired from references for isolates from mastitis cases and adequate referential strains (1, 3, 29) . Under the experimental conditions, the %T>MIC rate was based on the assumption that, in a restricted period (T0-T60) expressed in percentages (with assumption %T0-T60>MIC=100%), the ampicillin concentrations should exceed MIC values.
Results
During the experiment, all cows were clinically healthy and no adverse reactions were observed. The results of chromatographic measurements of ampicillin in cows' milk after single intramammary administration are shown in Table 1 and Fig. 1 . Pharmacokinetic analysis of the ampicillin concentration in cows' milk after intramammary administration. The pharmacokinetic results are presented in Table 2 . The research was carried out within 4.9 half-life's after administration of the drug. A very low value of AUCrest% was maintained. For the two-compartment model, the curves were classified on the basis of the difference between kd>kel. The kd value was more than nine times higher than the kel, which fully qualified the model for the two-compartment analysis. The elimination half-life calculated on the basis of kel determined by MRT0-t was about 2.35 h. It was therefore significantly shorter than t1/2kel determined on the basis of examination of the terminal part of the curve. This also confirmed the correct qualification to the two-compartment model. The two-compartment model and the corresponding rate constants are shown in Fig. 2 .
Examination of potential efficacy of ampicillin under in vitro conditions with the PK/PD model. According to the MIC values of aminopenicillins for bacteria isolated from mastitis cases presented in the references (1, 31), they are highly diversified and vary within a range of 0.25-32 µg/mL. For instance, the MIC values for referential strains are as follows: E. coli (MIC -2-8 µg/mL) and S. aureus (MIC -0.5-2 µg/mL). Further data are presented in Table 3 . It was determined that only in some isolates from mastitic cows, the ampicillin concentrations in the whole period T0-T60, were higher than the established MIC values for bacteria. Detailed results of the calculated %T (>MIC) indicator values for microorganisms isolated from mastitis cases are presented in Table 4 . M -arithmetic mean; SD -standard deviation; AUC0-t -area under the curve calculated between zero and the last sampling point; AUC0-inf -area under the curve calculated between zero and infinity; AUMC0-t -area under the first moment of curve calculated between zero and the last sampling point; AUMC0-inf -area under the first moment of curve calculated between zero and infinity; MRT0-t -mean residence time calculated for the last sampling point; MRT0-inf -mean residence time calculated for infinity; AUCrest% -percentage of the rest area under the curve; Cmaxmaximal concentration; tmax -time to rich maximal concentration; Clast -last measured concentration; tlast -time of the last measured concentration; kel -elimination rate constant; kd -distribution rate constant; t1/2kel -elimination half-life; t1/2kd -distribution half-life; B -concentration extrapolated by elimination phase; A -concentration extrapolated by distribution phase; C0 -zero concentration; k10 -elimination rate from milk compartment; k20 -elimination rate from tissue compartment; k12 -rate constant between milk and tissue concentration; k21 -rate constant between tissue and milk concentration; CL -total clearance; V1 -milk compartment volume; V2 -tissue compartment Fig. 2 . Two-compartment model of ampicillin elimination k10 -elimination rate from milk compartment; k20 -elimination rate from tissue compartment; k12 -rate constant between milk and tissue concentration; k21 -rate constant between tissue and milk concentration; imm. -intramammary administration 
Discussion
The pharmacokinetic characteristics of ampicillin after intramammary administration indicate a rapid elimination of the drug from milk. MRT0-t has a value many times lower than the determined t1/2kel and amounts to only 3.4 h. This means that the concentration of the drug in the milk drops relatively quickly and the process is very dynamic. The t1/2kel for the kinetics of intramammary administration means the sum of all elimination mechanisms that induce the suppression and withdrawal of the drug from the udder. The key elements of this process include transfer of the drug to the udder tissue, transfer of the drug to the entire organism, and elimination of the drug with milk. The proposed model assumes that the transfer to the udder tissue is represented by constant k12, and the transfer from the udder to milk by k21. Based on the calculations, it can be concluded that the transfer of the drug to the udder tissues is a very slow process compared to the reverse process i.e. the transfer from the udder tissue to milk. The rate of the transfer to the udder tissue is an over seventy-fold lower process than the transfer from the udder tissue to milk. This means that a small amount of the drug has a chance to enter the systemic circulation. The rate of elimination from the tissue compartment is expressed by the rate constant k20. This constant indicates rapid elimination of ampicillin from the general circulation. The speed of this process is almost 60 times greater than the elimination with milk; however, it entails a very small fraction of the drug. This means that a key to the elimination of ampicillin after intramammary administration is to eliminate it with milk. This is confirmed by the value of the kd to k10 ratio (1.001). V1 indicates the location of the drug in a small volume of milk. The value of V2 indicates a significant proportion of the tissue compartment at the disposal of the drug. It is, however, limited and its size indicates a transfer within the udder. Complete elimination of ampicillin reaching a level of 99.90% occurs at a time equal to 10 × t1/2kel. This means that assuming linear kinetics of the drug elimination over the time range analysed in this study (up to 60 h), ampicillin will be eliminated from the organism at the level of 99.90% after ca.123 h (5.125 d) post administration.
The observed course of the concentration of ampicillin in the milk on the concentration-time curves is similar to the curve of intravenously administered drugs. Only after intravenous administration can we observe an immediate maximal concentration in plasma. Subsequently, it decreases quickly as a result of distribution. In the case of ampicillin, the concentration-time curve has a steeper course (Fig. 1) . After approx. 10 to 24 h, the steep curve slopes for ampicillin decrease and remain curves of perivascularly administered medicines. With relatively low protein binding of ampicillin, the clear decrease in its concentration in cows' milk 4 h after administration was caused by absorption to mammary gland vesicles and, to a lower extent, by penetration to blood. In addition, after ca. 36 h from administration of ampicillin, the concentration-time curves were characterised by slow elimination, which lasted up to 60 h. During that time, the concentration of ampicillin exceeded the MRL value. However, after 60 h, the ampicillin level became lower than the MRL value.
There is no available scientific literature on the pharmacokinetics of ampicillin in cows' milk after intramammary administration. Therefore, the results had to be related only to the research taking into consideration intravascularly or intramuscularly administered aminopenicillins. Only the course of the concentration-time curve for milk after intravascular administration of ampicillin (10, 22, 23) can provide a reliable reference for concentration-time curves after intramammary administration of penicillins. In this investigation, after intramammary administration, ampicillin was detectable in milk for 2-60 h. However, intravenously administered ampicillin (6 mg/kg) in buffalo persisted in milk for only 8 h (22) . Consequently, this confirms the fact that parenterally administered acidic antibiotics are quickly eliminated from milk. In addition, quick aminopenicillin elimination from milk was observed after intravenous administration of this antibiotic in llamas (23) . The above-mentioned results of the retention time of ampicillin in milk after intravenous administration indicate limited suitability of the parenteral use of the indicated antibiotic in mastitis treatment.
Pharmacokinetic studies are essential for defining the rational dosing in individual species. Given the existing methodical and selective differences, the comparison of the pharmacokinetic indicators established in our studies on cows with those calculated for different species is unjustified. However, the differences result from the different routes of administration, dosage differences, different analytical techniques, and species characteristics. Therefore, out of necessity, only small differences in the studied indicators describing the behaviour of ampicillin in cows' milk after intramammary administration have been discussed in the literature. The fast rate of elimination with a large decrease in the concentration of ampicillin was recorded 24 h after administration of the drug. Additionally, at a designated withdrawal period for ampicillin in the milk, the concentrations of the antibiotic residues were lower than the predetermined value MRL, 4 µg/kg, within 60 h. Studies have shown variable level of sensitivity of microorganisms isolated from mastitis cases to ampicillin (1, 3, 29) . Based on the literature concerning pathogen sensitivity to aminopenicillins, assessment (under in vitro conditions with the use of %T>MIC) of potential efficacy of these antibiotics in mastitis cases was performed. The calculated results allow an assumption that during the treatment of mastitis induced by pathogens with low sensitivity to aminopenicillins (for example, MIC -E. coli -8 µg/mL, Enterobacteriaceae -8 µg/mL, Streptococcus epidermidis -13.50 µg/mL), the antibiotics should be re-administered already 12 h after the first administration. In the case of strains with high sensitivity to aminopenicillins (e.g. MICStaphylococcus aureus -0.5-2 µg/mL, Staphylococcus spp. -0.25-0.5 µg/mL, Streptococcus agalactiae -1.05-3.25 µg/mL), recommended doses should be sustained. At high MIC values established for highly ampicillin-sensitive pathogens, the regimen of dosing these penicillins ensures maintenance of their concentration above the MIC value (according to %T>MIC) for 50%-80% of effective time. The conducted research confirms the rationale of using the PK/PD model in order to verify the dosing regimen for other antibiotic groups and various indicators of the applied PK/PD model: AUC/MIC, Cmax/MIC, and %T>MIC.
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